ENLIVEN THERAPEUTICS

enliven-therapeutics-logo

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. The company's discovery process combines clinically validated biological targets and industry-leading chemistry to address the limitations of existing therapies. This approach allows us to ef๏ฌciently and effectively develop precision oncology therapeutics that enhance overall patient well-being. Founded in July 2019 by Sam Kintz, MBA, Joe Lyssikatos, PhD, and Anish Patel, PharmD, Enliven Therapeutics is based in Boulder, Colorado.

#SimilarOrganizations #People #Financial #Website #More

ENLIVEN THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science Therapeutics

Founded:
2019-01-01

Address:
Boulder, Colorado, United States

Country:
United States

Website Url:
http://www.enliventherapeutics.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
140 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Apache Global Site Tag


Similar Organizations

affinia-therapeutics-logo

Affinia Therapeutics

Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.

alx-oncology-logo

ALX Oncology

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

alloy-therapeutics-logo

Alloy Therapeutics

Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.

altay-therapeutics-logo

Altay Therapeutics

Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions.

black-diamond-therapeutics-logo

Black Diamond Therapeutics

Black Diamond Therapeutics is a precision oncology medicine company pioneering the discovery and development of small molecule.

calithera-biosciences-logo

Calithera Biosciences

Calithera Biosciences is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.

galera-therapeutics-logo

Galera Therapeutics

Galera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.

gallant-pet-logo

Gallant Pet

Gallant Pet is a pet service company that develops a stem cell therapy intended for dog wounds.

immpact-bio-logo

ImmPACT Bio

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

kanaph-therapeutics-logo

Kanaph Therapeutics

Kanaph Therapeutics is a leading biotech in oncology, auto-immune, and eye diseases with large molecules and small molecules.

mdi-therapeutics-logo

MDI Therapeutics

MDI Therapeutics is a operator of an discovery stage company focused on developing novel therapies for fibrotic diseases.

mitobridge-logo

Mitobridge

Mitobridge is discovering and developing small molecule therapeutics that improve mitochondrial functions.

neuronascent-logo

NeuroNascent

Neuronascent discovers and develops small molecule therapeutics for depression and neurodegenerative diseases.

phoenicis-logo

Phoenicis

Phoenicis focuses on developing therapies to provide hope and relief to people living with rare disease.

restore-vision-logo

Restore Vision

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

scorpion-therapeutics-logo

Scorpion Therapeutics

Scorpion Therapeutics is a precision oncology company that broadens the reach and impact of precision medicine for cancer patients.

signum-biosciences-logo

Signum Biosciences

Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.

siteone-therapeutics-logo

SiteOne Therapeutics

SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.

strand-therapeutics-logo

Strand Therapeutics

Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.

not_available_image

Synnovation Therapeutics

Synnovation Therapeutics is a precision oncology company that develops therapeutics that can improve the lives of people with cancer.

synthex-logo

SyntheX

SyntheX is a biotechnology firm developing highly specific drugs for previously undruggable targets to treat cancer and rare diseases.


Current Advisors List

not_available_image

Rich Heyman Board Member @ Enliven Therapeutics
Board_member

not_available_image

Mika Derynck Board Member @ Enliven Therapeutics
Board_member

not_available_image

Andrew Phillips Board Member @ Enliven Therapeutics
Board_member

jake-bauer_image

Jake Bauer Board Member @ Enliven Therapeutics
Board_member

Current Employees Featured

sam-kintz_image

Sam Kintz
Sam Kintz Co-Founder and CEO @ Enliven Therapeutics
Co-Founder and CEO
2019-01-01

anish-patel_image

Anish Patel
Anish Patel Co-founder and Chief Operating Of๏ฌcer @ Enliven Therapeutics
Co-founder and Chief Operating Of๏ฌcer

joe-lyssikatos_image

Joe Lyssikatos
Joe Lyssikatos Co-founder and Chief Scienti๏ฌc Of๏ฌcer @ Enliven Therapeutics
Co-founder and Chief Scienti๏ฌc Of๏ฌcer

Founder


anish-patel_image

Anish Patel

joe-lyssikatos_image

Joe Lyssikatos

sam-kintz_image

Sam Kintz

Investors List

surveyor-capital_image

Surveyor Capital

Surveyor Capital investment in Series B - Enliven Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series B - Enliven Therapeutics

boxer-capital_image

Boxer Capital

Boxer Capital investment in Series B - Enliven Therapeutics

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series B - Enliven Therapeutics

logos-capital_image

Logos Capital

Logos Capital investment in Series B - Enliven Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series A - Enliven Therapeutics

roche-venture-fund_image

Roche Venture Fund

Roche Venture Fund investment in Series A - Enliven Therapeutics

5am-ventures_image

5AM Ventures

5AM Ventures investment in Series A - Enliven Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Seed Round - Enliven Therapeutics

5am-ventures_image

5AM Ventures

5AM Ventures investment in Seed Round - Enliven Therapeutics

Official Site Inspections

http://www.enliventherapeutics.com Semrush global rank: 9.7 M Semrush visits lastest month: 114

  • Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
  • IP address: 54.176.110.96
  • Location: San Jose United States
  • Latitude: 37.3388
  • Longitude: -121.8914
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 95141

Loading ...

More informations about "Enliven Therapeutics" on Search Engine